4746 Stock Overview
Formosa Laboratories, Inc., together with its subsidiaries, engages in the manufacture and sale of active pharmaceutical ingredients (APIs) and ultraviolet absorbers worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 1/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
Formosa Laboratories, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NT$101.50 |
| 52 Week High | NT$121.00 |
| 52 Week Low | NT$76.70 |
| Beta | 0.80 |
| 1 Month Change | -0.98% |
| 3 Month Change | -12.50% |
| 1 Year Change | 29.46% |
| 3 Year Change | 76.22% |
| 5 Year Change | 144.87% |
| Change since IPO | 10.45% |
Recent News & Updates
Recent updates
Benign Growth For Formosa Laboratories, Inc. (TWSE:4746) Underpins Its Share Price
Apr 19
Here's Why Formosa Laboratories (TPE:4746) Has A Meaningful Debt Burden
Apr 19Does Formosa Laboratories, Inc.'s (TPE:4746) Weak Fundamentals Mean A Downturn In Its Stock Should Be Expected?
Mar 16What Type Of Returns Would Formosa Laboratories'(TPE:4746) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?
Feb 08Formosa Laboratories (TPE:4746) Is Making Moderate Use Of Debt
Jan 11
Formosa Laboratories's (TPE:4746) Earnings Are Growing But Is There More To The Story?
Dec 13Shareholder Returns
| 4746 | TW Pharmaceuticals | TW Market | |
|---|---|---|---|
| 7D | -3.8% | -2.2% | -1.6% |
| 1Y | 29.5% | 7.2% | 25.9% |
Return vs Industry: 4746 exceeded the TW Pharmaceuticals industry which returned 7.2% over the past year.
Return vs Market: 4746 exceeded the TW Market which returned 25.9% over the past year.
Price Volatility
| 4746 volatility | |
|---|---|
| 4746 Average Weekly Movement | 6.7% |
| Pharmaceuticals Industry Average Movement | 3.8% |
| Market Average Movement | 4.6% |
| 10% most volatile stocks in TW Market | 8.6% |
| 10% least volatile stocks in TW Market | 2.2% |
Stable Share Price: 4746 has not had significant price volatility in the past 3 months.
Volatility Over Time: 4746's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of TW stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1985 | n/a | Chih-Ping Yang | www.formosalab.com |
Formosa Laboratories, Inc., together with its subsidiaries, engages in the manufacture and sale of active pharmaceutical ingredients (APIs) and ultraviolet absorbers worldwide. It offers APIs in the areas of anticancer, anti-inflammatory and analgesic agents, MRI enhancing agents, cholesterol and phosphate binders, CNS agents, immunomodulators, respiratory agents, steroids, vitamin D derivatives, antibiotics, potassium binders, and other areas. The company also provides contract development and manufacturing services; solutions for manufacturing antibody-drug conjugates; and injectable manufacturing services.
Formosa Laboratories, Inc. Fundamentals Summary
| 4746 fundamental statistics | |
|---|---|
| Market cap | NT$12.15b |
| Earnings (TTM) | NT$126.24m |
| Revenue (TTM) | NT$4.36b |
96.7x
P/E Ratio2.8x
P/S RatioIs 4746 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4746 income statement (TTM) | |
|---|---|
| Revenue | NT$4.36b |
| Cost of Revenue | NT$2.44b |
| Gross Profit | NT$1.92b |
| Other Expenses | NT$1.80b |
| Earnings | NT$126.24m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.05 |
| Gross Margin | 44.11% |
| Net Profit Margin | 2.90% |
| Debt/Equity Ratio | 49.0% |
How did 4746 perform over the long term?
See historical performance and comparison